Antigen Discovery nets 2.5 million for malaria vaccine work
Irvine based Antigen Discovery Inc has secured a 2.5 million federal SBIR grant for a three year malaria vaccine project in partnership with Sanaria Inc. UC Irvine bred Felgner and Sanaria leaders underscore ADI's microarray platform to speed vaccine development and identify protective immune markers. The effort targets diagnostics and antigens to boost vaccine efficacy and licensure prospects.
MENTIONED IN THIS ARTICLE
Ntigen Discovery Inc
Irvine Biomed Company
Antigen
Xiaowu Liang
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Antigen and
Sanaria Inc
Maryland
Liang
Navy
UC Irvine
Phil Felgner
Imm- Port Therapeutics Inc
Felgner
Sanaria
Stephen L. Hoffman
ADI
Antigen Discovery Inc
Irvine
Also Mentioned on This Page
Biotech
South Coast Plaza
Mens Shop
Ludlow
J.crew
Thomas Mason
Orange County Exclusive
Bloomingdale’s Wing
San Diego
Bristol ST
Costa Mesa